Holen Sie sich die Stockscreener-App
0.922
4.83%
-0.0558
Schlusskurs vom Vortag:
$0.9778
Offen:
$0.98
24-Stunden-Volumen:
63,375
Relative Volume:
0.57
Marktkapitalisierung:
$70.53M
Einnahmen:
$11.03M
Nettoeinkommen (Verlust:
$-44.24M
KGV:
-1.4871
EPS:
-0.62
Netto-Cashflow:
$-42.61M
1W Leistung:
-12.21%
1M Leistung:
-6.02%
6M Leistung:
-13.03%
1J Leistung:
-13.84%
1-Tages-Spanne:
$0.92
$0.98
1-Wochen-Bereich:
$0.92
$1.06
52-Wochen-Spanne:
$0.7613
$1.39
Hyperfine Inc Stock (HYPR) Company Profile
Firmenname
Hyperfine Inc
Sektor
Branche
Telefon
866-796-6767
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Vergleichen Sie HYPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.922 | 70.53M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
112.53 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.47 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
365.48 | 139.65B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.17 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.34 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2022-04-14 | Eingeleitet | Wells Fargo | Overweight |
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
NeuroPace reports preliminary Q4 revenue - MSN
Hyperfine (NASDAQ:HYPR) Stock Price Up 8.2%What's Next? - MarketBeat
Hyperfine (NASDAQ:HYPR) Trading Up 8.2% – Here’s What Happened - Defense World
Hyperfine enters distro partnerships in Turkey, Israel, and Saudi Arabia - DOTmed HealthCare Business News
Pediatric MRI Market Top Companies StudySiemens Healthcare - openPR
Hyperfine’s Swoop System Software Approved in Europe - MPO-mag
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets - The Bakersfield Californian
Hyperfine (NASDAQ:HYPR) Shares Up 1.5%What's Next? - MarketBeat
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care - BioSpace
Hyperfine Announces Strategic Leadership Additions to Drive Grow - GuruFocus.com
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals - Oil City Derrick
Hyperfine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body - Oil City Derrick
Hyperfine's Swoop® MRI System Achieves Major Reimbursement Milestone with IAC Standards Update - StockTitan
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Hyperfine COO Thomas Teisseyre sells $2,380 in stock - Investing.com India
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings - Marketscreener.com
Hyperfine COO Thomas Teisseyre sells $2,380 in stock By Investing.com - Investing.com Canada
Hyperfine Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Posts Quarterly Earnings Results - MarketBeat
Analysts Are Updating Their Hyperfine, Inc. (NASDAQ:HYPR) Estimates After Its Third-Quarter Results - Simply Wall St
Is Hyperfine (NASDAQ:HYPR) In A Good Position To Invest In Growth? - Yahoo Finance
Hyperfine revenues up 56% to USD 3.64M in Q3 2024 - Medical Buyer
Hyperfine (HYPR) to Present at BTIG and Mizuho Healthcare Investor Conferences | HYPR Stock News - StockTitan
Hyperfine, Inc. to Participate in Upcoming Investor Conferences - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Hyperfine highlights robust Q3 growth, eyes European expansion - Investing.com UK
Hyperfine, Inc. Reports Record Revenue Growth in Q3 2024 - TipRanks
Hyperfine gets CE nod for expanded European launch of Swoop portable MR - DOTmed HealthCare Business News
Hyperfine reports Q3 EPS (14c), consensus (14c) - TipRanks
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results - The Manila Times
Hyperfine Reports Record Q3 Revenue, Up 56% YoY; Advances AI Brain Imaging Software | HYPR Stock News - StockTitan
Hyperfine Inc (HYPR) Q3 2024 Earnings: Revenue Surpasses Estimat - GuruFocus.com
Hyperfine gains CE mark for MRI brain imaging software - BioWorld Online
What To Expect From Hyperfine Inc (HYPR) Q3 2024 Earnings - Yahoo Finance
Hyperfine (HYPR) Set to Announce Earnings on Tuesday - Defense World
HYPRHyperfine, Inc. Latest Stock News & Market Updates - StockTitan
Guilford-based Hyperfine gains approval to sell portable imaging device in Europe - Hartford Business Journal
Hyperfine secures CE approval for Swoop system software By Investing.com - Investing.com South Africa
Hyperfine secures CE approval for Swoop system software - Investing.com India
Hyperfine Announces European Launch with CE Approval - Silicon Canals
Hyperfine (HYPR) to Release Earnings on Tuesday - MarketBeat
Hyperfine Announces Alzheimer’s Research with Swoop System Data - MPO-mag
Hyperfine's Swoop MRI system shows promise in Alzheimer's study - Investing.com
Hyperfine's Swoop MRI system shows promise in Alzheimer's study By Investing.com - Investing.com UK
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality - BioSpace
Finanzdaten der Hyperfine Inc-Aktie (HYPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hyperfine Inc-Aktie (HYPR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 16 '24 |
Sale |
1.05 |
2,746 |
2,883 |
91,027 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 16 '24 |
Sale |
0.88 |
2,753 |
2,423 |
93,773 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 16 '24 |
Sale |
1.11 |
3,230 |
3,585 |
96,526 |
0.93%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):